• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RYR1 相关肌病患者的运动功能表现。

Motor function performance in individuals with RYR1-related myopathies.

机构信息

National Institute of Nursing Research, National Institutes of Health, Bethesda, Maryland, USA.

L'Escale, Service de Médecine Physique et de Réadaptation Pédiatrique, Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, F-69500, Bron, France. Université de Lyon, F-69000, Lyon, France. Université Lyon 1, F-69100, Villeurbanne, France.

出版信息

Muscle Nerve. 2019 Jul;60(1):80-87. doi: 10.1002/mus.26491.

DOI:10.1002/mus.26491
PMID:31004442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6619391/
Abstract

INTRODUCTION

The objective of this study was to obtain a 6-month natural history of motor function performance in individuals with RYR1- related myopathy (RYR1-RM) by using the Motor Function Measure-32 (MFM-32) and graded functional tests (GFT) while facilitating preparation for interventional trials.

METHODS

In total, 34 participants completed the MFM-32 and GFTs at baseline and 6-month visits.

RESULTS

Motor deficits according to MFM-32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM-32 (D1; r ≥ 0.770, P < 0.001). Motor Function Measure-32 and GFT scores did not reflect any change in performance between baseline and 6-month visits.

DISCUSSION

The MFM-32 and GFTs detected motor impairment in RYR1-RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80-87, 2019.

摘要

简介

本研究的目的是通过使用运动功能测量-32 (MFM-32)和分级功能测试(GFT)来获得 RYR1 相关肌病(RYR1-RM)个体 6 个月的运动功能表现自然史,同时为干预试验做准备。

方法

共有 34 名参与者在基线和 6 个月访视时完成了 MFM-32 和 GFTs。

结果

根据 MFM-32,运动缺陷主要出现在站立和转移域(D1;平均 71%)。在 GFT 中,参与者上下楼梯所需的时间最长(>7.5 秒)。由 GFT 等级确定的功能性运动与 MFM-32(D1;r≥0.770,P<0.001)呈强相关。MFM-32 和 GFT 评分均未反映出基线与 6 个月访视之间运动功能的任何变化。

讨论

MFM-32 和 GFTs 检测到 RYR1-RM 的运动障碍,6 个月内保持稳定。因此,这些措施可能适合评估治疗干预对运动功能的变化。肌肉神经 60:80-87,2019。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/28cc4c3b5ecb/MUS-60-80-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/373814125494/MUS-60-80-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/8f346b460b00/MUS-60-80-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/96b2dd4a8b4b/MUS-60-80-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/20533dcf4d2b/MUS-60-80-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/28cc4c3b5ecb/MUS-60-80-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/373814125494/MUS-60-80-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/8f346b460b00/MUS-60-80-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/96b2dd4a8b4b/MUS-60-80-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/20533dcf4d2b/MUS-60-80-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4410/6619391/28cc4c3b5ecb/MUS-60-80-g005.jpg

相似文献

1
Motor function performance in individuals with RYR1-related myopathies.RYR1 相关肌病患者的运动功能表现。
Muscle Nerve. 2019 Jul;60(1):80-87. doi: 10.1002/mus.26491.
2
RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.RYR1 相关肌病:葡萄牙一家三级医院的 17 例患者的临床、组织病理学和遗传异质性。
J Neuromuscul Dis. 2017;4(1):67-76. doi: 10.3233/JND-160199.
3
Cored in the act: the use of models to understand core myopathies.在行动中剖析:利用模型理解核心肌病。
Dis Model Mech. 2019 Dec 19;12(12):dmm041368. doi: 10.1242/dmm.041368.
4
[Hot spot mutation screening of RYR1 gene in diagnosis of congenital myopathies].[先天性肌病诊断中RYR1基因热点突变筛查]
Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Oct 18;46(5):691-7.
5
A review of core myopathy: central core disease, multiminicore disease, dusty core disease, and core-rod myopathy.核心肌病的综述:中央核疾病、多肌病、尘状核疾病和核棒肌病。
Neuromuscul Disord. 2021 Oct;31(10):968-977. doi: 10.1016/j.nmd.2021.08.015. Epub 2021 Sep 17.
6
Core myopathies - a short review.核心型肌病——简短综述。
Acta Myol. 2020 Dec 1;39(4):266-273. doi: 10.36185/2532-1900-029. eCollection 2020 Dec.
7
Quantitative reduction of RyR1 protein caused by a single-allele frameshift mutation in RYR1 ex36 impairs the strength of adult skeletal muscle fibres.RYR1 外显子 36 的单等位基因突变导致 RyR1 蛋白数量减少,从而损害成年骨骼肌纤维的强度。
Hum Mol Genet. 2019 Jun 1;28(11):1872-1884. doi: 10.1093/hmg/ddz025.
8
6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies.6 分钟步行试验作为一组 RYR1 相关肌病患者疾病进展和疲劳性的测量指标。
Orphanet J Rare Dis. 2018 Jul 3;13(1):105. doi: 10.1186/s13023-018-0848-9.
9
Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.隐性RYR1相关中央核性肌病患者常见和多变的临床、组织学及影像学表现。
Neuromuscul Disord. 2017 Nov;27(11):975-985. doi: 10.1016/j.nmd.2017.05.016. Epub 2017 May 30.
10
Correlation of phenotype with genotype and protein structure in RYR1-related disorders.RYR1 相关疾病表型与基因型及蛋白结构的相关性。
J Neurol. 2018 Nov;265(11):2506-2524. doi: 10.1007/s00415-018-9033-2. Epub 2018 Aug 28.

引用本文的文献

1
Long-term Natural History of Pediatric Dominant and Recessive -Related Myopathy.儿科显性和隐性遗传性肌病的长期自然病史。
Neurology. 2023 Oct 10;101(15):e1495-e1508. doi: 10.1212/WNL.0000000000207723. Epub 2023 Aug 29.
2
RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022.与兰尼碱受体1(RYR-1)相关疾病国际研究研讨会:从机制到治疗 美国宾夕法尼亚州匹兹堡,2022年7月21日至22日
J Neuromuscul Dis. 2023;10(1):135-154. doi: 10.3233/JND-221609.
3
Ryanodine Receptor 1-Related Myopathies: Quantification of Intramuscular Fatty Infiltration from T1-Weighted MRI.

本文引用的文献

1
The Utility of the Supine-to-Stand Test as a Measure of Functional Motor Competence in Children Aged 5⁻9 Years.仰卧到站立测试作为5至9岁儿童功能性运动能力测量方法的效用
Sports (Basel). 2017 Sep 12;5(3):67. doi: 10.3390/sports5030067.
2
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy.与胶原蛋白VI相关的肌病和与层粘连蛋白α2相关的肌营养不良症的上肢结局指标。
Neuromuscul Disord. 2017 Mar;27(3):278-285. doi: 10.1016/j.nmd.2016.11.017. Epub 2016 Dec 5.
3
Pathogenic mechanisms in centronuclear myopathies.
Ryanodine 受体 1 相关肌病:T1 加权 MRI 评估肌肉内脂肪浸润。
J Neuromuscul Dis. 2021;8(4):657-668. doi: 10.3233/JND-200549.
中央核肌病的致病机制。
Front Aging Neurosci. 2014 Dec 19;6:339. doi: 10.3389/fnagi.2014.00339. eCollection 2014.
4
Congenital myopathies: Natural history of a large pediatric cohort.先天性肌病:一个大型儿科队列的自然病史。
Neurology. 2015 Jan 6;84(1):28-35. doi: 10.1212/WNL.0000000000001110. Epub 2014 Nov 26.
5
Systematic review of timed stair tests.定时楼梯测试的系统评价
J Rehabil Res Dev. 2014;51(3):335-50. doi: 10.1682/JRRD.2013.06.0148.
6
Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy.先天性肌营养不良和先天性肌病患者运动功能测量的拉施分析。
Arch Phys Med Rehabil. 2014 Nov;95(11):2086-95. doi: 10.1016/j.apmr.2014.06.005. Epub 2014 Jun 25.
7
Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale.II型脊髓性肌萎缩症和先天性肌病患者的疲劳:疲劳严重程度量表评估
Qual Life Res. 2014 Jun;23(5):1479-88. doi: 10.1007/s11136-013-0565-8. Epub 2013 Nov 9.
8
Genotype-phenotype correlations in recessive RYR1-related myopathies.隐性 RYR1 相关肌病的基因型-表型相关性。
Orphanet J Rare Dis. 2013 Aug 6;8:117. doi: 10.1186/1750-1172-8-117.
9
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.6 分钟步行试验和其他杜氏肌营养不良症的临床终点:来自多中心研究的可靠性、相关性和最小临床重要差异。
Muscle Nerve. 2013 Sep;48(3):357-68. doi: 10.1002/mus.23905. Epub 2013 Jul 17.
10
Responsiveness of the motor function measure in neuromuscular diseases.运动功能测量在神经肌肉疾病中的反应性。
Arch Phys Med Rehabil. 2012 Dec;93(12):2251-6.e1. doi: 10.1016/j.apmr.2012.05.025. Epub 2012 Jun 13.